Alnylam Pharmaceuticals, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Sep 2026Filed 29/10/2026 | Jun 2026Filed 29/10/2026 | Mar 2026Filed 29/10/2026 | Sep 2025Filed 29/10/2026 | Jun 2025Filed 29/10/2026 | Mar 2025Filed 29/10/2026 | Sep 2024Filed 30/10/2025 | Jun 2024Filed 30/10/2025 |
|---|---|---|---|---|---|---|---|---|
| $1,458 | $1,291 | — | $1,249 | $774 | $594 | $501 | $660 | |
| $2,167 | $164 | $206 | $293 | −$72 | −$18 | −$112 | −$17 | |
| $15.72 | $1.21 | — | $2.14 | −$0.55 | −$0.14 | −$0.87 | −$0.13 | |
| 138 | 138 | — | 137 | 131 | 130 | 129 | 127 |
Trend